Access to high cost medicines in Australia: ethical perspectives

Access to "high cost medicines" through Australia's Pharmaceutical Benefits Scheme (PBS) is tightly regulated. It is inherently difficult to apply any criteria-based system of control in a way that provides a fair balance between efficient use of limited resources for community needs...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Christine Y, Macneill, Paul, Williams, Ken, Day, Ric
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2412887/
https://www.ncbi.nlm.nih.gov/pubmed/18489760
http://dx.doi.org/10.1186/1743-8462-5-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2412887/
https://www.ncbi.nlm.nih.gov/pubmed/18489760
http://dx.doi.org/10.1186/1743-8462-5-4

Ejemplares similares